UGER ROBERT (Chief Scientific Officer) sold 3.65K shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $39.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/9/2021ACC: 0001062993-21-003543
Officer· Chief Scientific Officer
Since Jan 2021
-3.65K
Net shares
Net seller
$39.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.65K acquired · 7.29K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+3.65K
Price / share
$0.30
Trade value
$1.10K
% of position
New position
4/7/2021
0.00→3.65K
Common Shares
Direct
Shares
−3.65K
Price / share
$10.82
Trade value
$39.45K
% of position
New position
4/7/2021
3.65K→0.00
Total
Net shares
+0.00
Net value
-$38.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 4/7/2021 | M · Option Exercise | +3.65K | $0.30 | $1.10K | New position | 0.00 | 3.65K |
| Common Shares Direct | 4/7/2021 | S · Sale | −3.65K | $10.82 | $39.45K | New position | 3.65K | 0.00 |
| Total | +0.00 | -$38.35K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
3.65K shares
Shares
−3.65K
Strike price
0.3012
Held after
113.02K
Exercisable
—
4/7/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares3.65K shares | 4/7/2021 | M · Option Exercise | −3.65K | 0.3012 | — | 113.02K |